Startups, philanthropy, billionaires, academia, neuromodulation, psychedelics, AI and new therapies in bipolar, autism, and Parkinson’s with Rob Malenka
About this episode
Matias interviews Rob Malenka about the complexities and challenges in psychiatry and the potential of new therapies.
Matias interviews Rob Malenka. In this episode, we discuss: Why progress in psychiatry is slow because the brain is the most complex organ and many disorders are highly heterogeneousThe bottlenecks including weak replicability in research, academic politics, perverse incentives, and pharma’s avoidance of neuropsychiatryHow breakthroughs require early detection, rigorous science, and bridging academia with biotech through venture philanthropyHow success depends on mission-driven, ethical peopl...
More episodes of Business Trip
- Brain Organoids: from Space to AI with Alysson Muotri
- Inside Philanthropy’s Role in Mental & Brain Health
- Rick Perry on paving the way for Ibogaine in America
- Brain Shuttles: A New Path Into the Brain with James Gorman of the Wyss Institute
- AI and the future of therapy with Luis Voloch of Jimini Health
- Transforming Skin Cells into Neurons to Treat Alzheimer’s with Brendon Boot of Skin2Neuron
Explore listener stats, chart rankings, contacts and more on the Business Trip podcast page.